These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 31441862)
21. Sequential Versus Individual Saphenous Vein Grafting During Coronary Arterial Bypass Surgery. Park SJ; Kim HJ; Kim JB; Jung SH; Choo SJ; Lee JW; Chung CH Ann Thorac Surg; 2020 Apr; 109(4):1165-1173. PubMed ID: 31539513 [TBL] [Abstract][Full Text] [Related]
22. Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting. Nocerino AG; Achenbach S; Taylor AJ Am J Cardiol; 2013 Nov; 112(10):1576-9. PubMed ID: 24035160 [TBL] [Abstract][Full Text] [Related]
23. Safety outcomes of anti-platelet therapy post coronary artery bypass graft surgery: A systematic review and network meta-analysis of randomized control trials. Hasan SU; Pervez A; Shah AA; Shah SD; Aslam M; Arshad A; Rajput AS; Zubair MM Perfusion; 2024 May; 39(4):684-697. PubMed ID: 36803180 [TBL] [Abstract][Full Text] [Related]
25. Influence of lipoproteins and antiplatelet agents on vein graft patency 1 year after coronary artery bypass grafting. Zhu J; Zhu Y; Zhang M; Xue Q; Hu J; Liu H; Wang R; Wang X; Zhao Q J Thorac Cardiovasc Surg; 2022 Mar; 163(3):1030-1039.e4. PubMed ID: 32359899 [TBL] [Abstract][Full Text] [Related]
26. Comparative effectiveness of clopidogrel versus aspirin as a maintenance monotherapy 1 year after coronary artery bypass grafting. Kim JS; Kang Y; Sohn SH; Hwang HY Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 37039835 [TBL] [Abstract][Full Text] [Related]
27. A systematic review of guidelines for dual antiplatelet therapy in coronary artery bypass graft. Zhang ZZ; Zhang SZ; Zhou HM; Fan YQ; Liu MH; Zhong XB; Yang DY; Guo Y; Zhuang XD; Liao XX Eur J Clin Invest; 2021 Jan; 51(1):e13405. PubMed ID: 32926588 [TBL] [Abstract][Full Text] [Related]
28. Angiographic outcomes of radial artery versus saphenous vein in coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials. Cao C; Manganas C; Horton M; Bannon P; Munkholm-Larsen S; Ang SC; Yan TD J Thorac Cardiovasc Surg; 2013 Aug; 146(2):255-61. PubMed ID: 22871565 [TBL] [Abstract][Full Text] [Related]
29. Thrombelastographic hypercoagulability and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): a randomized controlled trial. Rafiq S; Johansson PI; Kofoed KF; Lund JT; Olsen PS; Bentsen S; Steinbrüchel DA Platelets; 2017 Dec; 28(8):786-793. PubMed ID: 28277060 [TBL] [Abstract][Full Text] [Related]
30. Comparative effectiveness of antiplatelet therapies for saphenous venous graft occlusion and cardiovascular outcomes: a network meta-analysis. Hasan SU; Pervez A; Afreen M; Imam B; Shah SD; Shah AA; Siddiqui SA; Zubair MM; Osho A Minerva Cardiol Angiol; 2024 Aug; ():. PubMed ID: 39087882 [TBL] [Abstract][Full Text] [Related]
31. Antiplatelet Therapy and Coronary Artery Bypass Grafting: Analysis of Current Evidence With a Focus on Acute Coronary Syndrome. Gupta S; Belley-Cote EP; Agahi P; Basha A; Jaffer I; Mehta S; Schwalm JD; Whitlock RP Can J Cardiol; 2019 Aug; 35(8):1030-1038. PubMed ID: 31376904 [TBL] [Abstract][Full Text] [Related]
32. The effect of total arterial grafting on medium-term outcomes following coronary artery bypass grafting. Légaré JF; Hassan A; Buth KJ; Sullivan JA J Cardiothorac Surg; 2007 Oct; 2():44. PubMed ID: 17956634 [TBL] [Abstract][Full Text] [Related]
33. Composite versus conventional coronary artery bypass grafting strategy for the anterolateral territory: study protocol for a randomized controlled trial. Drouin A; Noiseux N; Chartrand-Lefebvre C; Soulez G; Mansour S; Tremblay JA; Basile F; Prieto I; Stevens LM Trials; 2013 Aug; 14():270. PubMed ID: 23971858 [TBL] [Abstract][Full Text] [Related]
34. Radial artery versus saphenous vein as the second conduit for coronary artery bypass surgery: A meta-analysis. Gaudino M; Rahouma M; Abouarab A; Leonard J; Kamel M; Di Franco A; Demetres M; Tam DY; Tranbaugh R; Girardi LN; Fremes SE J Thorac Cardiovasc Surg; 2019 May; 157(5):1819-1825.e10. PubMed ID: 30551962 [TBL] [Abstract][Full Text] [Related]
35. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y Circulation; 1988 Jun; 77(6):1324-32. PubMed ID: 3286040 [TBL] [Abstract][Full Text] [Related]
36. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) Trial. Kulik A; Le May MR; Voisine P; Tardif JC; Delarochelliere R; Naidoo S; Wells GA; Mesana TG; Ruel M Circulation; 2010 Dec; 122(25):2680-7. PubMed ID: 21135365 [TBL] [Abstract][Full Text] [Related]
37. Ticagrelor versus aspirin and vein graft patency after coronary bypass: A randomized trial. Kulik A; Abreu AM; Boronat V; Kouchoukos NT; Ruel M J Card Surg; 2022 Mar; 37(3):563-570. PubMed ID: 34961950 [TBL] [Abstract][Full Text] [Related]
39. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
40. Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society. Fitchett D; Eikelboom J; Fremes S; Mazer D; Singh S; Bittira B; Brister S; Graham J; Gupta M; Karkouti K; Lee A; Love M; McArthur R; Peterson M; Verma S; Yau T Can J Cardiol; 2009 Dec; 25(12):683-9. PubMed ID: 19960127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]